 | Up a level |
König, D; Savic Prince, S; Hayoz, S; Zens, P; Berezowska, S; Jochum, W; Stauffer, E; Braunersreuther, V; Trachsel, B; Thierstein, S; Mark, M; Schmid, S; Curioni-Fontecedro, A; Addeo, A; Opitz, I; Guckenberger, M; Früh, M; Betticher, D C; Ris, H-B; Stupp, R; ... (2023). Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14. ESMO open, 8(4), p. 101595. BMJ 10.1016/j.esmoop.2023.101595
Rogers, S; Baumert, B; Blanck, O; Böhmer, D; Boström, J; Engenhart-Cabillic, R; Ermis, E; Exner, S; Guckenberger, M; Habermehl, D; Hemmatazad, H; Henke, G; Lohaus, F; Lux, S; Mai, S; Minasch, D; Rezazadeh, A; Steffal, C; Temming, S; Wittig, A; ... (2023). Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO). Strahlentherapie und Onkologie, 199(1), pp. 113-114. Springer 10.1007/s00066-022-02021-1
Rogers, S; Baumert, B; Blanck, O; Böhmer, D; Boström, J; Engenhart-Cabillic, R; Ermis, E; Exner, S; Guckenberger, M; Habermehl, D; Hemmatazad, H; Henke, G; Lohaus, F; Lux, S; Mai, S; Minasch, D; Rezazadeh, A; Steffal, C; Temming, S; Wittig, A; ... (2022). Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO). Strahlentherapie und Onkologie, 198(10), pp. 919-925. Springer 10.1007/s00066-022-01991-6
König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]. ESMO open, 7(3), p. 100494. Elsevier 10.1016/j.esmoop.2022.100494
Moustakis, C; Blanck, O; Chan, Mkh; Boda-Heggemann, J; Andratschke, N; Duma, M-N; Albers, D; Bäumer, C; Fehr, R; Körber, S A; Schmidhalter, D; Alraun, M; Baus, W W; Beckers, E; Dierl, M; Droege, S; Ebrahimi Tazehmahalleh, F; Fleckenstein, J; Guckenberger, M; Heinz, C; ... (2022). Planning benchmark study for SBRT of liver metastases: Results of the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. International journal of radiation oncology, biology, physics, 113(1), pp. 214-227. Elsevier 10.1016/j.ijrobp.2022.01.008
König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials. ESMO open, 7(2), p. 100455. Elsevier 10.1016/j.esmoop.2022.100455
Wilke, L; Moustakis, C; Blanck, O; Albers, D; Albrecht, C; Avcu, Y; Boucenna, R; Buchauer, K; Etzelstorfer, T; Henkenberens, C; Jeller, D; Jurianz, K; Kornhuber, C; Kretschmer, M; Lotze, S; Meier, K; Pemler, P; Riegler, A; Röser, A; Schmidhalter, Daniel; ... (2021). Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose. Strahlentherapie und Onkologie, 197(9), pp. 836-846. Springer 10.1007/s00066-021-01799-w
De Bruycker, A; Spiessens, A; Dirix, P; Koutsouvelis, N; Semac, I; Liefhooghe, N; Gomez-Iturriaga, A; Everaerts, W; Otte, F; Papachristofilou, A; Scorsetti, M; Shelan, M.; Siva, S; Ameye, F; Guckenberger, M; Heikkilä, R; Putora, P. M.; Zapatero, A; Conde-Moreno, A; Couñago, F; ... (2020). PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC cancer, 20(1), p. 406. BioMed Central 10.1186/s12885-020-06911-4
Peters, S; Felip, E; Dafni, U; Belka, C; Guckenberger, M; Irigoyen, A; Nadal, E; Becker, Antje; Vees, H; Pless, M; Martinez-Marti, A; Tufman, A; Lambrecht, M; Andratschke, N; Piguet, A C; Kassapian, M; Roschitzki-Voser, H; Rabaglio, Manuela; Stahel, R A; Vansteenkiste, J; ... (2019). Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. Lung cancer, 133, pp. 83-87. Elsevier 10.1016/j.lungcan.2019.05.001
Klement, Rainer J; Abbasi-Senger, N; Adebahr, S; Alheid, H; Allgaeuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Eble, M J; Ernst, I; Gerum, S; Habermehl, D; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, Natalie Désirée; ... (2019). The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases. BMC cancer, 19(1), p. 173. BioMed Central 10.1186/s12885-019-5362-5
Klement, R J; Hoerner-Rieber, J; Adebahr, S; Andratschke, N; Blanck, O; Boda-Heggemann, J; Duma, M; Eble, M J; Eich, H C; Flentje, M; Gerum, S; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, K H; Klass, Natalie Désirée; Krempien, R; Lohaus, F; Petersen, C; ... (2018). Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. Radiotherapy and oncology, 127(2), pp. 246-252. Elsevier 10.1016/j.radonc.2018.02.016
Ghadjar, Pirus; Hayoz, S; Genitsch Gratwohl, Vera; Zwahlen, DR; Hölscher, T; Gut, P; Guckenberger, M; Hildebrandt, G; Müller, AC; Putora, Paul Martin; Papachristofilou, A; Stalder, L; Biaggi-Rudolf, C; Sumila, M; Kranzbühler, H; Najafi, Y; Ost, P; Azinwiq, NC; Reuter, C; Bodis, S; ... (2017). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU international, 120(5B), E45-E51. Wiley 10.1111/bju.13742
Tanadini-Lang, S; Rieber, J; Filippi, A R; Fode, M M; Streblow, J; Adebahr, S; Andratschke, N; Blanck, O; Boda-Heggemann, J; Duma, M; Eble, M J; Ernst, I; Flentje, M; Gerum, S; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, Natalie Désirée; ... (2017). Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiotherapy and oncology, 123(2), pp. 182-188. Elsevier 10.1016/j.radonc.2017.01.003
